IL-15 transpresentation by ovarian cancer cells improves CD34 <sup>+</sup> progenitor-derived NK cell's anti-tumor functionalityMarcos Vidal-Manrique, Harry Dolstra, Thomas Nieuwenstein et al.|OncoImmunology|2025Cited by 10
Engineering of CD34+ progenitor-derived natural killer cells with higher-affinity CD16a for enhanced antibody-dependent cellular cytotoxicityP.M.M. van Hauten, Harry Dolstra, Paul K.J.D. de Jonge et al.|Cytotherapy|2023Cited by 9
Good manufacturing practice production of an off-the-shelf CD34+ progenitor-derived NK cell product with preserved anti-tumor functionality post-infusion in NOD/SCID/IL2Rgnull miceLaura Hooijmaijers, Harry Dolstra, Marcos Vidal-Manrique et al.|Cellular and Molecular Life Sciences|2025Cited by 6
Engineering with EP2/EP4 knockout and IL-15 transpresentation renders stem cell-derived NK cells self-persistent and resistant to PGE2 inhibitionMarcos Vidal-Manrique, Harry Dolstra, Laura Hooijmaijers et al.|Frontiers in Immunology|2026Cited by 0
Correction: Engineering with EP2/EP4 knockout and IL-15 transpresentation renders stem cell-derived NK cells self-persistent and resistant to PGE2 inhibitionMarcos Vidal-Manrique, Harry Dolstra, Laura Hooijmaijers et al.|Frontiers in Immunology|2026Cited by 0